Delivery Order SPE2DB24D9802-SPE2DB25FJLDD
- Not listed
- The Defense Logistics Agency awarded a $1,404.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 500 units of Fexofenadin 180mg, with an ultimate completion date of December 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 500 tablets of Fexofenadine HCL 180 mg, with a ceiling value of $1,269.54. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,049.84 delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for fexofenadine hydrochloride with an ultimate completion date of April 20, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical supply to Department of Defense healthcare facilities...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $21,296.08 from the Defense Logistics Agency's Medical Supply Chain division on August 6, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a discrete pharmaceutical supply requirement with an ultimate completion date of August 7, 2025. The delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency's Medical Supply Chain division on August 20, 2025. This delivery order, with an ultimate completion date of August 21, 2025, represents a single task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. This delivery order, which carries no set-aside designation, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $41,020.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group is a registered SAM.gov vendor that specializes in distributing pharmaceutical products, including branded...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $1,562.31 from the Defense Logistics Agency's Medical Supply Chain division on August 21, 2025. This delivery order, which has no set-aside designation, is part of DMS Pharmaceutical Group's larger $499.999 billion Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valid through November...
- The Defense Logistics Agency issued a delivery order valued at $5,170.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, is issued under the company's larger Indefinite Delivery Contract with DLA valued at $499.99 million and valid through November 2026. The delivery order employs firm fixed-price pricing and carries no...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLDDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,057.95 to DMS Pharmaceutical Group Inc. for the supply of Fexofenadine HCL 180 mg tablets (500-count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in SAM.gov since 2001 and specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to federal healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. This IDC enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs of military health facilities worldwide. The company has demonstrated a robust track record of fulfilling federal pharmaceutical requirements, positioning it as a critical supplier within the Department of Defense healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/26/25 |